Abstract
The addictive drugs alcohol, morphine, cocaine, and amphetamine are each associated with the development of tolerance and physical dependence. Changes in gene expression occur in cell culture and in vivo with the administration of these centrally-acting drugs. This article reviews those experiments that have studied drug-induced alterations in gene transcription.
Ethanol has diverse effects on the amounts of messenger RNA molecules within the central nervous system. Ion channels, neuropeptides, membrane receptors, and immediate early genes represent several regulated mRNAs. The effects are selective, however, as many other specific products are not altered. Evidence for a genetic predisposition to ethanol use reinforces the importance of the genotype.
Opioids, cocaine, and amphetamine also affect gene transcription. Messenger RNAs studied have included many of those demonstrated to be altered by alcohol use. Interestingly, use of any of these drugs alters the expression of immediate early genes. These genes may represent an initial step in the pathway that leads to drug addiction.
The composite of drug-induced changes in gene expression results in the cellular responses of tolerance and dependence. The characterization of these changes should provide a better understanding of the molecular mechanisms of drug addiction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baudry M., Shahi K., and Gall C. (1988)Brain Res. 464, 313–318.
Beitner-Johnson D. and Nestler E. J. (1991)J. Neurochem. 57, 344–347.
Belknap K., Halti N. R., Goebel D. H., and Lame M. (1983)Behav. Genet. 13, 383.
Blasig J., Herz A., Reinhold K., and Zieglgansberger S. (1973)Psychopharmacology 33, 19–38.
Blum K., Noble E. P., Sheridan P. J., Montgomery A., Ritchie T., Jagadeeswarian P., Nogami H., Briggs A. H., and Cohn J. B. (1990)JAMA 263, 2055–2060.
Brandt M., Gullis R. J., Fischer K., Buchen C., Hamprecht B., Moroder L., and Wunsch E. (1976)Nature 276, 311–312.
Brinton R. E., Gruener R., Deshmukh P., and Yamamura H. I. (1986)Neurosci. Lett. 67, 213–217.
Brodie M. S., Shefner S. A., and Dunwiddie T. V. (1988)Alcohol Clin. Exp. Res. 12, 116.
Caboche J., Vernier P., Julien J. F., Rogard M., Mallet J., and Besson M. J. (1991)J. Neurochem. 56, 428–435.
Carlen P. L., and Wu P. H. (1988)Int. Rev. Neurobiol. 29, 161–189.
Chang K. J., Miller R. J., and Cuatrecasas P. (1978)Mol. Pharm. 14, 961–970.
Chang S. L., Squinto S. P., and Harlan R. E. (1988)Biochem. Biophys. Res. Commun. 157, 698–704.
Charness M. E., Querimet L. A., and Diamond I. (1986)J. Biol. Chem. 261, 3164–3169.
Chiara G. D. and Imperato A. (1988)Proc. Natl. Acad. Sci. USA 85, 5274–5278.
Chu N.S. (1984)Brain Res. 311, 348–352.
Cohen B. M., Van Nguyen T., Babb S. M., and Hyman S. (1990)Soc. Neurosci. Abs. 16, 309.1.
Cox B. M. and Osman O. H. (1970)Br. J. Pharm. 38, 157–170.
Dave J. R., Eiden L. E., Karanian J. W., and Eskay R. L. (1986)Endocrinology 118, 280–286.
Dave J. R., Tabakoff B., and Hoffman P. L. (1990)Mol. Pharm. 37, 367–371.
Deitrich R. A., Dunwiddie T. V., Harris R. A., and Erwin V. G. (1989)Pharm. Rev. 41, 489–537.
Dolin S., Little H., Hudspith M., Pagonis C., and Littleton J. (1987)Neuropharmacology 26, 275–279.
Evans C. J., Hammond D. L., and Frederickson R. C. A. (1988) The Opioid Peptides, inThe Opiate Receptors. G. W. Pasternak, ed., Humana, Clifton, NJ.
Fleming E. W., Woodson M. E., and Tewari S. (1981)J. Neurosci. Res. 6, 511–524.
Fontenot G. K., Cass W. A., and Vulliet P. R. (1987)Proc. W. Pharm. Soc. 30, 263.
Goelet P., Castellucci V. F., Schacher S., and Kandel E. R. (1986)Nature 322, 419–422.
Goldman D., Lister R. G., and Crabbe J. C. (1987)Brain Res. 420, 220–226.
Graybiel A. M., Moratealla R., and Robertson H. A. (1990)Proc. Natl. Acad. Sci. USA 87, 6912–6916.
Guitart X., Hayward M., Nisenbaum L. K., Beitner-Johnson D. B., Haycock J. W., and Nestler E. J. (1990)J. Neurosci. 10, 2649–2659.
Harper J. C., Brennan C. H., and Littleton J. M. (1989)Neuropharmacology 28, 1299–1302.
Hayward M. D., Duman R. S., and Nestler E. J. (1990)Brain Res. 525, 256–265.
Iadarola M. J., Yeung C. L., Hoo Y., and Quinn J. P. (1990)Soc. Neurosci. 16, 526.10.
Ishizawa H., Dave J. R., Liu L., Tabakoff B., and Hoffman P. L. (1989)Eur. J. Pharm. 189, 119.
Johannesson T., Steele W. J., and Becker B. A. (1972)Acta Pharm. Tox. 31, 353–368.
Johnson S. M. and Fleming W. W. (1989)Pharm. Rev. 41, 435–488.
Klee W. A. and Nirenberg M. (1974)Proc. Natl. Acad. Sci. USA 71, 3474–3477.
Koob G. F. and Bloom F. E. (1988)Science 242, 715–723.
Kornblum H. I., Loughlin S. E., and Leslie F. M. (1987)Dev. Brain Res. 31, 45–52.
Kozel N. J., and Adams E. H. (1986)Science 234, 970–974.
Kuhar M. J., Pert C. B., and Snyder S. H. (1973)Nature 245, 447–450.
Law P. Y., Hom D. S., and Loh H. H. (1983)Mol. Pharm. 24, 413–424.
Law P. Y., Ungar H. G., Hom D. S., and Loh H. H. (1985)Biochem. Pharm. 34, 9–17.
Le F., Wilce P., Cassady I., Hume D., and Shanley B. (1990)Neurosci. Lett. 120, 271–274.
Lightman S. L. and Young W. S. (1987)Nature 328, 643–645.
Lightman S. L. and Young W. S. (1988)J. Physiol. 403, 511–523.
Little H. J., Dolin S. J., and Halsey M. J. (1986)Life Sci. 39, 2059–2065.
Mackler S. A. and Eberwine J. H. (1990)Soc. Neurosci. 16, 526.11.
Mackler S. A. and Eberwine J. H. (1991)Soc. Neurosci. 17, 568.3.
Mereu G., Fadda F., and Gessa G. L. (1984)Brain Res. 292, 63–69.
Mochly-Rosen D., Chang F. H., Cheever L., Kim M., Diamond I., and Gordon A. S. (1988)Nature 333, 848–850.
Montpied P., Morrow A. L., Karanian J. W., Ginns E. I., Martin B. M., and Paul S. M. (1991)Mol. Pharm. 39, 157–163.
Morrow A. L., Suzdak P. D., Karanian J. W., and Paul S. M. (1988)J. Pharm. Exp. Ther.,246, 158–164.
Nestlet E. J., Erdos J. J., Terwilliger R., Duman R. S., and Tallman J. F. (1989)Brain Res. 476, 230–239.
Nestler E. J. and Tallman J. F. (1988)Mol. Pharm. 33, 127–132.
North R. A. (1986)Trends Neurosci. 9, 114–117.
O'Brien C. P. (1975)Pharm. Rev. 27, 535–543.
Poherecky L. A. and Brick J. (1977)Brain Res. 134, 174–179.
Pritchett D. B., Sontheimer H., Shivers B. D., Ymer S., Kettenmann N., Schofield P. R., and Seeburg P. N. (1989)Nature 338, 582–585.
Robertson H. A., Peterson M. R., Murphy K., and Robertson G. S. (1989)Brain Res. 503, 346–349.
Rogers J., Madamba S. G., Staunton D. A., and Siggins G. R. (1986)Brain Res. 35, 253–262.
Romualdi P., Lesa G., and Ferri S. (1990)Ann. 1st Super Sanita 26, 43–46.
Schuckit M. A. (1985)JAMA 254, 2614–2617.
Schwartz J. P. (1988)Brain Res. 427, 141–146.
Sheng M. and Greenberg M. E. (1990)Neuron 4, 477–485.
Simonds W. F. (1988)Endocrine Rev. 9, 200–212.
Sonnenberg J. L., Rausch F. J., Morgan J. I., and Curran T. (1989)Science 246, 1622–1624.
Sorensen S., Palmer M., Dunwiddie T., and Hoffer B. (1980)Science 210, 1143–1145.
Sorensen S., Carter D., Marwaha J., Baker R., and Freedman R. (1981)J. Stud. Alcohol 42, 908–917.
Suzdak P. D., Schwartz R. D., Skolnick P., and Paul S. M. (1986)Proc. Natl. Acad. Sci. USA 83, 4071–4075.
Tecott L. H., Barchas J. D., and Eberwine J. H. (1988)Science 240, 1661–1164.
Tewari S., Fleming E. W., and Noble E. P. (1975)J. Neurochem. 24, 561–569.
Trujillo K. A. and Akil H. (1991)Science 251, 85–87.
Uhl G. R., Ryan J. P., and Schwartz J. P. (1988)Brain Res. 459, 391–397.
Valvarius P., Hoffman P. L., and Tabakoff B. (1989)J. Neurochem. 52, 492–497.
Van Gelder R. N., von Zastrow M. E., Yool A., Dement W. C., Barchas J. D., and Eberwine J. H. (1990)Proc. Natl. Acad. Sci. USA 87, 1663–1667.
Vincent S., Tsiokas L., Zhang S. C., Aiken S. P., Mcardle J. J., and Watson M. (1990)Soc. Neurosci. Abs. 16, 112.8.
von Zastrow M. E., Barchas J. D., and Eberwine J. H. (1991)NIDA Res. Monograph, in press.
Wafford K. A., Burnett D. M., Dunwiddie T. V., and Harris R. A. (1990)Science 249, 291–293.
Young S. T., Porrino L. J., and Iadorola M. J. (1991)Proc. Natl. Acad. Sci. USA 88, 1291–1295.
Zigmond R. E., Schwarzschild M. A., and Rittenhouse A. R. (1989)Ann. Rev. Neurosci. 12, 415–461.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mackler, S.A., Eberwine, J.H. The molecular biology of addictive drugs. Mol Neurobiol 5, 45–58 (1991). https://doi.org/10.1007/BF02935612
Issue Date:
DOI: https://doi.org/10.1007/BF02935612